About Humorigin Biotechnology

About company

Humorigin Biotechnology was established in 2002. The company's vision is to establish an international-level biotech new drug company. Committed to solving diseases that threaten human health in the 21st century. The core focus of the project is the development of new drugs for cancer immune cell therapy. Source One's business model is to introduce potential new drug candidates through cooperation with international partners, and then add value and innovation through resource integration.